FDA Adverse Event Injury Summary report: N

INTRALASE FS2

MDR report key: 7692070 · Received July 16, 2018

Report

Report Number
3006695864-2018-01500
Event Type
Injury
Date Received
July 16, 2018
Date of Event
June 25, 2018
Report Date
October 30, 2020
Manufacturer
JOHNSON & JOHNSON SURGICAL VISION
Product Code
HNO
UDI-DI
05050474573451
PMA / PMN Number
K060372
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS CORRECTION MDR IS BEING SUBMITTED TO ADDRESS INACCURATE INFORMATION IN SECTION F ON THE XML VERSION OF THE PREVIOUS SUBMISSION CAUSED BY A SOFTWARE GLITCH IN THE TRANSMISSION PROCESS. THE INTERNAL NON-CONFORMANCE NUMBERS FOR THIS SOFTWARE ISSUE ARE NR-0148919 AND CAPA-010215.

Additional Manufacturer Narrative · 1

A REVIEW OF RECORDS RELATED TO THE DEVICE INCLUDING LABELING, COMPLAINT TRENDING, AND RISK DOCUMENTATION WILL BE PERFORMED. UPON COMPLETION OF THIS REVIEW, IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED."

Description of Event or Problem · 1

IT WAS REPORTED THAT A LASER VISION CORRECTION PATIENT HAD SURGERY ON (B)(6) 2018 AND PRESENTED ON (B)(6) 2018 WITH DIFFUSE LAMELLAR KERATITIS (DLK) IN BOTH EYES (OU) POST TREATMENT. THERE WAS MORE IN THE RIGHT EYE (OD) THAN THE LEFT EYE (OS), SUB-LAMELLAR INFILTRATE. THE TOPICAL STEROID DOSAGE WAS INCREASED USING MEDROL PACK AND THE FLAPS WERE LIFTED AND IRRIGATED. IT WAS STATED THAT THE PATIENT HAD NO LOSS OF BEST CORRECTED VISUAL ACUITY (BCVA). THE PATIENT WAS CONCERNED FOR RECOVERY. PATIENT REPORTED SYMPTOMS ARE NOT INTERFERING WITH DAILY ACTIVITIES. BCVA FROM (B)(6) 2018: RIGHT EYE PRE-OP 20/20 -.75 X -2.00 X 0, LEFT EYE PRE-OP 20/20 -1.00 X -1.50 X 0.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
533479 INTRALASE FS2 FEMTOSECOND LASER HNO JOHNSON & JOHNSON SURGICAL VISION 20005D 05050474573451

Patients

Seq Age Sex Outcome Treatment
1 30 YR Required Intervention WAVELIGHT (B)(6)